Ascletis Pharma Inc. has been included in the list of eligible securities under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong...
-
-
Recent Updates
- Chinese Regulators Tighten Approval for Humanoid IPOs Amid Unitree Robotics Debut
- TÜV Rheinland Greater China President Xia Bo Attends 2026 Gulangyu Forum
- Kazakhstan’s Privatization Drive Opens IPO Opportunities in Hong Kong
- Concerns Rise Over Ford’s Collaborations with Chinese Companies
- Ford’s Business Ties with China Trigger National Security Concerns, DOT Official Warns
- Concerns Arise Over Ford’s Affiliations with Chinese Firms
- Nike’s Ouster from S&P 100 Signals Deep Market Cap Decline
- Legal Battle Unfolds for Huawei in New York Amid Allegations
- Strategic Deadline Set by EU to Address China’s Soaring Trade Imbalance
- China’s Influence on Global Antimony Market Forces Economies to Rethink Strategies
Blogroll